Doing what others do: norms, science, and collective action on global warming

Does rhetoric highlighting social norms or mentioning science in a communication affect individuals’ beliefs about global warming and/or willingness to take action? We draw from framing theory and collective-interest models of action to motivate hypotheses that are tested in two large web-based survey-experiments using convenience samples. Our results show that attitudes about global warming, support for policies that would reduce carbon emissions, and behavioral intentions to take voluntary action are strongly affected by norm- and science-based interventions. This has implications for information campaigns targeting voluntary efforts to promote lifestyle changes that would reduce greenhouse gas emissions

Climate projections and their impact on policy and practice

This article examines the relationship between projections of climate change and the responses to those projections. First, it discusses uncertainty and its role in shaping not only the production of climate projections but also the use of these projections by decision makers. We find that uncertainty critically affects the way climate projections move from useful to usable, where usefulness is defined by scientists' perception of users' needs, and usability is defined by users' perception of what knowledge can be readily applied to their decision. From the point of view of the natural scientist, we pose that there is an uncertainty fallacy, that is, a belief that the systematic reduction of uncertainty in climate projections is required in order for the projections to be used by decision makers. Second, we explore the implications of climate projections for policy and decision making, using examples from the seasonal climate forecast applications literature as an analog. We examine constraints and opportunities for their application in policy and practice and find that over-reliance on science and technical solutions might crowd out the moral imperative to do what is needed to improve livelihoods and to guarantee ecosystems' long-term sustainability. We conclude that, in the context of high uncertainty, decision makers should not look for ‘perfect’ forecasts, but seek to implement knowledge systems that integrate climate projections with other kinds of knowledge and that consider the multiple stressors that shape their decision environment. Copyright © 2010 John Wiley & Sons, Ltd. For further resources related to this article, please visit the WIREs websitePeer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/78059/1/71_ftp.pd

Five ways to enhance the impact of climate science

Policy-making is rarely driven by evidence alone. Thus, climate scientists who adopt an ‘evidence-based’ mindset, expecting more science to lead automatically to better policy, are likely to be disappointed. Instead, embracing an ‘evidence-informed’ attitude to policy-making will be more productive, recognising that evidence must be deployed in such a way as to interact persuasively with other factors. Using the 5th Assessment Report of the IPCC as inspiration, this commentary argues that climate scientists would do well to consider five ideas and ultimately embrace an evidence-informed approach to presenting evidence.This work is taken from a larger PhD project currently being undertaken in the Department of Geography at the University of Cambridge. This work is very kindly funded by the Economic and Social Research Council (grant number ES/I901957/1) and by the Homerton College Charter Scholarship scheme. I would like to thank S. E. Owens, A. Donovan and W. M. Adams for comments, and D. Watson for help with the figures.This is the accepted manuscript. The final version is available in Nature Climate Change 4, 522–524 (2014) doi:10.1038/nclimate2270 . http://www.nature.com/nclimate/journal/v4/n7/full/nclimate2270.htm

Essential features of responsible governance of agricultural biotechnology

Agricultural biotechnology continues to generate considerable controversy. We argue that to address this controversy, serious changes to governance are needed. The new wave of genomic tools and products (e.g., CRISPR, gene drives, RNAi, synthetic biology, and genetically modified [GM] insects and fish), provide a particularly useful opportunity to reflect on and revise agricultural biotechnology governance. In response, we present five essential features to advance more socially responsible forms of governance. In presenting these, we hope to stimulate further debate and action towards improved forms of governance, particularly as these new genomic tools and products continue to emerge

Public health and valorization of genome-based technologies: a new model

<p>Abstract</p> <p>Background</p> <p>The success rate of timely translation of genome-based technologies to commercially feasible products/services with applicability in health care systems is significantly low. We identified both industry and scientists neglect health policy aspects when commercializing their technology, more specifically, Public Health Assessment Tools (PHAT) and early on involvement of decision makers through which market authorization and reimbursements are dependent. While Technology Transfer (TT) aims to facilitate translation of ideas into products, Health Technology Assessment, one component of PHAT, for example, facilitates translation of products/processes into healthcare services and eventually comes up with recommendations for decision makers. We aim to propose a new model of valorization to optimize integration of genome-based technologies into the healthcare system.</p> <p>Methods</p> <p>The method used to develop our model is an adapted version of the Fish Trap Model and the Basic Design Cycle.</p> <p>Results</p> <p>We found although different, similarities exist between TT and PHAT. Realizing the potential of being mutually beneficial justified our proposal of their relative parallel initiation. We observed that the Public Health Genomics Wheel should be included in this relative parallel activity to ensure all societal/policy aspects are dealt with preemptively by both stakeholders. On further analysis, we found out this whole process is dependent on the Value of Information. As a result, we present our LAL (Learning Adapting Leveling) model which proposes, based on market demand; TT and PHAT by consultation/bi-lateral communication should advocate for relevant technologies. This can be achieved by public-private partnerships (PPPs). These widely defined PPPs create the innovation network which is a developing, consultative/collaborative-networking platform between TT and PHAT. This network has iterations and requires learning, assimilating and using knowledge developed and is called absorption capacity. We hypothesize that the higher absorption capacity, higher success possibility. Our model however does not address the phasing out of technology although we believe the same model can be used to simultaneously phase out a technology.</p> <p>Conclusions</p> <p>This model proposes to facilitate optimization/decrease the timeframe of integration in healthcare. It also helps industry and researchers to come to a strategic decision at an early stage, about technology being developed thus, saving on resources, hence minimizing failures.</p

Market-driven production of biospecimens and the role of NHS hospital-led biobanks

Biobanks are vital for biospecimen production in research, despite the regulatory, recruitment and commercial difficulties they face. We conducted interviews with clinicians, researchers, volunteers who recruit biobank participants, regulators and NHS managers about the integration of a biobank into an NHS hospital. We show that medical waste collected for biomedical research acquires its socio-ethical and economic value from the level of integration (both technologically and organisationally) of the biobank into the NHS hospital. There is extensive investment in a range of intellectual and commercial relationships and labour among stakeholders involved in the production of biospecimens. It is not only the boundaries of research, clinical care and commercialisation of biospecimens that blur but also those of volunteerism and citizenship. Hospital-led biobanks provide an opportunity to study the intertwining of biomedical innovation and healthcare